Lilli Ann Wolf-Gouveia

Lilli Ann Wolf-Gouveia is a prominent inventor based in Bahama, NC (US). She has made significant contributions to the field of medical science, particularly in the modulation of potassium channels. With a total of 3 patents, her work focuses on developing compounds that can treat various neurological disorders.

Latest Patents

One of her latest patents is titled "Heterocycles as potassium channel modulators." This invention provides compounds, compositions, and methods that are useful in treating diseases by modulating potassium ion flux through voltage-dependent potassium channels. The invention specifically addresses central and peripheral nervous system disorders, including migraine, Parkinson's disease, and Alzheimer's disease, among others. It also aims to serve as a neuroprotective agent to prevent strokes and related conditions.

Career Highlights

Lilli Ann Wolf-Gouveia is currently associated with Icagen, Inc., where she continues her innovative work. Her research has the potential to significantly impact the treatment of various neurological conditions, improving the quality of life for many patients.

Collaborations

Some of her notable coworkers include Thomas Eugene Christos and George Salvatore Amato. Their collaborative efforts contribute to the advancement of research in the field of potassium channel modulation.

Conclusion

Lilli Ann Wolf-Gouveia stands out as a dedicated inventor whose work in potassium channel modulation is paving the way for new treatments in neurology. Her contributions are vital to the ongoing research and development in this important area of medicine.

Profile summary based on public USPTO records.